Laurus Labs is currently trading at Rs. 364.70, up by 5.65 points or 1.57% from its previous closing of Rs. 359.05 on the BSE.
The scrip opened at Rs. 358.00 and has touched a high and low of Rs. 365.65 and Rs. 356.30 respectively. So far 37811 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 385.80 on 25-Jan-2021 and a 52 week low of Rs. 61.90 on 24-Mar-2020.
Last one week high and low of the scrip stood at Rs. 365.00 and Rs. 341.00 respectively. The current market cap of the company is Rs. 19191.58 crore.
The promoters holding in the company stood at 28.76%, while Institutions and Non-Institutions held 24.00% and 47.24% respectively.
Laurus Labs has won the prestigious Golden Peacock Award for excellence in corporate governance 2020. Instituted in 1991 by the Institute of Directors (IOD), India, the Golden Peacock Award is regarded as a global stamp of Corporate Excellence. This is the first year that the company has won this coveted award.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1861.70 |
Dr. Reddys Lab | 1389.35 |
Cipla | 1506.15 |
Lupin | 2228.00 |
Zydus Lifesciences | 972.70 |
View more.. |